21
transcriptional heterogeneity. Inference of clonal membership from scRNA-seq is currently unreliable.
22
We propose DENDRO, an analysis method for scRNA-seq data that detects genetically distinct subclones, 23 assigns each single cell to a subclone, and reconstructs the evolutionary tree. DENDRO utilizes 24 information from single nucleotide mutations in transcribed regions and accounts for single-cell level 25 expression stochasticity and technical noise. The accuracy of DENDRO is benchmarked on spike-in 26 datasets and on scRNA-seq data with known subpopulation structure. We applied DENDRO to two 27 scRNA-seq data sets, where the new approach allowed us to elucidate the interplay between genetic 28 and transcriptomic intratumor variation. Tumor initiation, progression, metastasis and relapse are mediated by DNA alterations [1] . Single 35 nucleotide alteration (SNA) is a basic type of DNA alteration that can affect the transcriptome and 36 contribute to intratumor heterogeneity [2] . Intratumor heterogeneity is a key mediator of patients' 37 response to treatment, as clonal selection can lead to the emergence of subclones that are drug 38 resistant [3] . Thus, identifying subclonal DNA alterations and assessing their impact on subclonal 39 transcriptional dynamics can elucidate the mechanisms of tumor evolution and determine potential 40 gene targets for therapy. To characterize intratumor genetic heterogeneity, most prior studies have 41 used bulk tumor DNA sequencing [4] [5] [6] [7] [8] [9] [10] [11] , but these approaches have limited resolution and power [12] .
42
Breakthroughs in single-cell genomics promise to reshape cancer research by allowing comprehensive 43 cell type classification and rare subclone identification. For example, in breast cancer, single-cell DNA 44 sequencing (scDNA-seq) was used to distinguish normal cells from malignant cells, the latter of which 45 were further classified into subclones [13] [14] [15] . However, scDNA-seq still suffers from low coverage, 46 intensive labor and low consistency, hindering its widespread adoption in the cancer field [16] . Single-47 cell RNA sequencing (scRNA-seq), on the other hand, is comparatively more mature and cost effective.
48
ScRNA-seq technologies such as Smart-seq2 [17] , , and 10X Genomics Chromium TM , which 49 can simultaneously profile thousands of cells with reasonable cost, have advanced tumor transcriptome 50 profiling to single cell resolution [19] . Previous single-cell studies revealed novel insights into the 51 developmental and immunological programs of gene expression in glioblastoma and breast cancer [20, 52 21]. Kim et al. and Tirosh et al. used scRNA-seq to elucidate drug target pathways and drug response 53 variability across samples and tumor metastasis [22, 23] . More recently, studies have focused on tumor 54 cellular architecture and tumor cell lineage in gliomas, leading to new expression signatures that are 55 predictive of prognosis [24] [25] [26] . However, despite the recognized importance of clonal DNA mutations in 56 tumor pathogenesis, this crucial aspect has not been explored in detail by these scRNA-seq studies, due 57 to the lack of appropriate computational methods for analyzing DNA-level mutation heterogeneity using 58 scRNA-seq data.
59
Only a small portion of the SNAs of each cell are expected to be seen in the read output of scRNA-seq.
60
To be sequenced, a SNA needs to fall in a transcribed region of the genome, at a location within the 61 transcript that will eventually be read. Gene transcription in single cells is typically bursty [27] [28] [29] , and 62 thus an SNA residing in a gene that is expressed at the bulk tissue level may not be observed in a 63 particular cell, simply because the mutated allele, by chance, is not expressed in the given cell. We refer 64 to alleles that are not captured due to expression stochasticity as biological dropouts. Even if a mutated 65 allele is expressed, it has to be successfully converted to cDNA and then sequenced to be represented in 66 the final read output; we refer to alleles lost at this step as technical dropouts. In addition to dropout 67 events, post-transcriptional modification, such as RNA editing, and sequencing errors impede both 68 sensitivity and specificity of SNA discovery. As a result, methods developed for single cell SNA detection 69 using scDNA-seq, such as Monovar [30] , as well as methods designed for SNA detection in bulk DNA or 70 RNA sequencing data do not yield accurate results in the scRNA-seq setting [31] [32] [33] [34] [35] [36] .
71
Intratumor genetic heterogeneity gives rise to intratumor transcriptomic heterogeneity, and cell-to-cell 72 transcriptional variation is driven by inter-clonal competition. Thus, in the analysis of scRNA-seq data of 73 tumor samples, the accurate classification of cells into clones and the characterization of each clone's 74 genetic alterations should be an integral step. The potential of identifying subclonal DNA mutations 75 using scRNA-seq data and the prospect of using these alterations for clonal inference has not been 76 extensively explored. This analysis gap is compounded by the lack of technology for profiling DNA 77 mutations and RNA expression in the same cell with acceptable accuracy, throughput, and cost.
78
Although one can apply scDNA-seq and scRNA-seq to the same tumor, the mutation analysis and RNA 79 quantification could not be conducted in the same set of cells.
80
Here we develop a new statistical and computational framework -DNA based EvolutionNary tree 81 preDiction by scRNA-seq technOlogy (DENDRO) -that reconstructs the phylogenetic tree for cells 82 sequenced by scRNA-seq based on genetic divergence calculated from DNA-level mutations. DENDRO 83 assigns each cell to a clone in the tree, and, for each clone, infers its mutation profile. DENDRO achieves 84 high power to detect genetically divergent subclones by addressing challenges unique to scRNA-seq, 85 including transcriptional variation and technical noise. A DENDRO clustering of scRNA-seq data allows 86 joint genetic and transcriptomic analysis on the same set of cells. We evaluate the accuracy of DENDRO 87 through spike-in benchmark data sets, and then illustrate its application through two case studies. Figure 1A shows an overview of DENDRO's analysis pipeline. Input data can be in fastq or BAM format.
100
For fastq files, we recommend STAR 2-pass method for alignment, which accounts for splicing junctions 101 and achieve higher mapping quality [37] . In the next step, GATK tools are used for SNA detection [38] ; 102 parameters for this step are chosen to allow high sensitivity but low specificity, since the SNA loci will be 103 further refined in downstream analysis (see Methods and Figure S1 for details). Per cell counts of total 104 read coverage ( matrix) and mutation allele read coverage ( matrix) at SNA locations are extracted.
105
Based on these matrices, DENDRO then computes a cell-to-cell genetic divergence matrix, where entry 106 ( , ') of the matrix is a measure of the genetic divergence between cells and '. Details of this genetic 107 divergence evaluation are given in the next section. DENDRO next clusters the cells into genetically 108 distinct clones based on this pairwise divergence matrix, and selects the number of clones based on 109 inspection of the intra-cluster divergence curve. Reads from the same clone are then pooled together, 110 and the SNA profile for each clone is re-estimated based on the pooled reads, significantly improving 111 upon the previous SNA profiles computed at the single cell level. Finally, DENDRO generates a parsimony 112 tree using the clone-level mutation profiles, to more accurately reconstruct their evolutionary 113 relationship.
115
Genetic divergence evaluation 116 Due to the high rate of biological and technical dropout, SNA detection by GATK within each cell lacks 117 sensitivity. We also expect a high false positive rate due to the known high base error rate in scRNA-seq 118 protocols. Given this, simple approaches such as the Hamming or Euclidean distance computed using 119 the raw SNA genotype matrix or the allele frequency matrix do not accurately measure the genetic 120 divergence between cells.
121
To more accurately estimate the cell-to-cell genetic divergence, we developed a statistical model that 122 accounts for technical dropout, sequencing error and expression stochasticity. Consider two cells, 123 and ', and let * and *+ index the clonal group to which the cells belong. That is, * = *+ if cells and ' 124 come from the same subclone and thus share the same SNA profile. Let * = ( *-, … , */ ) be the 125 mutation allele read counts for this cell at the SNA sites profiled, and let * = ( *-, … , */ ) be the 126 total read counts at these sites. We define the genetic divergence between the two cells as 127 **+ = log * , * 6 * , * 6 , * = * 6 = **+ 7 / 78-
128
where ** 6 7 = −log *7 , * 6 7 *7 , * 6 7 , * = * 6
129
In other words, ** 6 is the negative log likelihood of the mutation allele counts of cells and ′, given 130 the total read counts and the event that the two cells belong to the same clone. If and ′ have 131 mutations in mismatched positions, the likelihood for * , *+ conditioned on * = * 6 would be small, 132 giving a large value for ** 6 . By the assumption of independence between sites, ** 6 is the sum of ** 6 7 , 133 where ** 6 7 is the contribution of mutation site to the divergence measure. In characterizing the 134 conditional distribution for *7 and * 6 7 , we use a Beta-Binomial distribution to model expression 135 stochasticity and a Binomial model to capture sequencing errors and rare RNA-editing events, please see 136 Methods for details.
137
To illustrate how transcriptional stochasticity affects the divergence calculation, consider the toy 138 example shown in Figure 1B , where we compare the contributions of two mutation sites, and ', to 139 the pairwise divergence between celland cell < . First, note that site is identical to site ′ in 140 mutation allele frequency and total read count in both cells. However, they contribute different values 141 of **+ due to their different expression stochasticity: Gene is bursty, that is, expression of both alleles 142 is sporadic leading to a U-shaped mutation allele frequency distribution across cells. In contrast, gene ′ 143 is constitutive, that is, expression of both alleles is stable, leading to a bell shaped allele-frequency 144 distribution across cells. Thus, biological dropout is more likely for gene than for gene ′, which means 145 that, despite the identical mutation allele frequency and total coverage, * = * > 7 < * = * > 7+ .
Accuracy assessment using in silico spike-ins 147
We designed a spike-in procedure to assess the accuracy of DENDRO and to make realistic power 148 projections for subclone detection (Figure 2a ). The procedure, in its basic mode, starts with an assumed 149 evolutionary tree, where the leaves are clades and mutations can be placed on the branches. In the 150 absence of prior information, a simple tree structure is used, such as the one shown in Figure 2A .
151
Parameters of simulation are (1) 
200
This dataset is composed of 116 cells from three different tumors derived from one single patient: a each loci ( Figure S4B , C). For majority sites, only few cells have nonzero read coverage, highlighting the 214 fact that many mutations are missed due to technical and biological dropout ( Figure S4D ) [32] [33] [34] [35] [36] .
215
We compared 4 different clustering methods: DENDRO, hierarchical clustering based on the primary 216 genotype matrix generated by GATK ( *7 = 1 when a mutation is detected for cell , *7 = 217 0 otherwise), hierarchical clustering based on the / matrix that preserve the variant allele 218 information and hierarchical clustering based on gene expression ( ). DENDRO gives the cleanest 219 separation between the three populations with adjusted Rand Index of 0.932 (1.0 indicates perfect 220 clustering, Figure 3A) , as compared to 0.754 for Z matrix (Figure 3B ), 0.519 for X/N ( Figure 3C ) and 0.489 221 for expression ( Figure 3D) . Inspection of the graph shows that, as expected, divergence between 222 primary tumor and metastasis exceeds divergence between patient sample and PDX sample, as 223 PDX_mRCC clusters with Pt_mRCC rather than PDX_pRCC. All of the other three methods successfully 224 separated the primary sample from the metastatic samples, but cannot differentiate between the two 225 metastasis samples. For DENDRO, the intra-cluster divergence curve kinks sharply at 3, and thus we 226 stopped at 3 clusters ( Figure 3E and Methods). We annotated the clusters as PDX_mRCC, PDX_pRCC and 227 Pt_mRCC by their cell compositions (Table S1A ). The fact that DENDRO found little mixing of cells 228 between the three tumors, and low genetic heterogeneity within each tumor, is unsurprising given how 229 these tumors were derived: Since relapsed metastasis consists of cells that have already underwent a 230 selection bottleneck, and since the PDX tumor is seeded by a small subsample of cells from the original 231 tumor, it is not surprising that no subclones are detected in each of the three tumors [40] [41] [42] . By 232 maximum likelihood, we called a total of 13,454 mutations after pooling the cells within each cluster 233 ( Figure 3F and Methods). The unrooted phylogenetic tree computed with the revised mutation profiles 234 confirms that genetic divergence between metastasis and primary is greater than divergence between 235 PDX and primary sample.
236
DENDRO enables simultaneous clonal assignment and transcriptomic profiling of the same set of cells.
237
Plot of smoothed expression ordered by DENDRO shows unique expression patterns within each 238 subclone ( Figure S6 ). We focused on the comparison of the two metastasized cell populations 239 (metastasis to lung and patient derived mouse xenograph). Even though PDX_mRCC was derived from 240 Pt_mRCC, the DENDRO analysis found substantial genetic divergence between the two cell populations.
241
To investigate further, we performed a differential expression analysis between PDX_mRCC and 242 Pt_mRCC with scDD and MAST, detecting 74 significant differentially expressed genes (Methods, Figure   243 S7E, Table S2A ) [43] [44] [45] . Gene ontology analysis classified these 74 genes into two subgroups: immune-244 related genes and cancer-related genes ( 
246
On the other hand, cancer related differentially expressed genes overlap with the pathways including 247 hypoxia, KRAS signaling, mTORC1 signaling and epithelial mesenchymal transition.
248
Simultaneously, we compare the mutation profiles of these two clones. 9521 locus have different 249 mutated allele counts between these two populations and were further annotated by ANNOVAR [47].
250
After filtering, the preserved variants associated with 24 out of 74 differential expressed genes (Table   251 S2A 
Analysis of scRNA-seq dataset of primary breast cancer
We next demonstrate the application of DENDRO to a primary breast cancer dataset [21] . We focused 269 on two tumors (BC03 and BC09) that have the most cell sequenced (Table S3 and Figure S8 ). BC03 270 includes cells from primary tumor (here after BC03P) and from regional metastatic lymph nodes (here 271 after BC03LN). 132 single cell transcriptomes were profiled by Smart-seq protocol [17] . For this analysis, 272 we will first examine whether DENDRO can separate BC03 and BC09 based on their genetic differences, 273 and then, jointly characterize the transcriptomic and genetic changes between cells in lymph nodes and 274 primary resections.
275 GATK [46] detected a total of 2,364,823 mutation sites across the 132 cells, 353,647 of which have 276 mutation frequency greater than 5% and smaller than 95%, and were retained for downstream analysis 277 ( Figure S8A , B, C). Figure 4 shows the clustering given by DENDRO. DENDRO separates BC09 cells from 278 BC03 cells with 100% accuracy ( Figure 4A ). The intra-cluster divergence curve kinks at 5 clones between 279 BC03 and BC09, yielding 3 subclones for BC03 and 2 for BC09 ( Figure 4A , Figure S8D and Table S1B ).
280
Within BC03 likelihood, we pick the top 10,000 variants to construct a phylogenetic tree ( Figure 4C ). As expected, the 290 two BC09 clusters are far separate from the BC03 clusters. Within BC03, the length of the branches 291 shows that the subclone containing mostly cells from lymph nodes (labeled BC03LN_1) is genetically 292 similar to the Mix_2 clone, and distant from the Mix_1 clone ( Figure 4C ).
293
To profile clone-specific gene expression patterns, we first plot window-smoothed expression with cells 294 grouped by DENDRO clustering [23] . Unsurprisingly, there are broad chromosome-level differences in 295 expression patterns between groups (Figure S9 ), most likely due to copy number aberrations and/or 296 epigenetic remodeling. Next, we focused on the expression of the PAM50 genes ( Figure 4D ), and found 297 substantial differences in their expression between subclones. DENDRO detected one rare subclone, 298 BC09_2, with only six cells (<5% of the total number of cells) which has strong basal-like signature. 
307
We next conducted a transcriptome-wide search for pathways that have differential expression 308 between clones (Methods and Table S4 ), and assessed their overlap with pathways that are 309 differentially mutated between clones. Focusing on tumor BC03, pathways for G2M checkpoint and 310 KRAS signaling are up-regulated in lymph node metastasis subclone BC03LN_1, while pathways for 311 estrogen response and apoptosis are down-regulated, indicating more invasive phenotype (Table S4E) .
312
In addition, GAPDH is up-regulated in the metastatic clone (BC03LN_1) and down-regulated in the two 313 mix-cell clones, consistent with previous findings [51, 52] (Figure S10D ). Differentially expressed genes 314 between other subclone pairs in BC03 are also enriched in estrogen response, apoptosis, and DNA 315 repair. (Table S4C , D). In parallel, subclone-specific mutated genes are highly enriched in cancer-related 316 pathways including MYC target, G2M checkpoints and mitotic spindle, and immune related pathways 317 such as, interferon response, TNF-a signaling and inflammatory response (Table S4) . Interestingly, few of 318 the differentially mutated genes are associated with estrogen and androgen responses, suggesting that 319 differential expression of hormone related genes are not mediated directly by genetic mutations in 320 these pathways. This is consistent with the recent studies that found epigenetic alteration, such as 321 histone acetylation and methylation, to underlie hormones receptor signaling in breast cancer [53] [54] [55] [56] .
322
DNA-RNA joint analysis between other subclones are included in the Table S4 and Figure S10 
339
Importantly, the genetic divergence used by DENDRO for cell clustering is based solely on allelic 340 expression ratios and do not reflect the difference in total expression between cells at mutation sites.
341
Thus, DENDRO differs from and complements existing tools that cluster cells based on total expression.
342
In fact, as shown by spike-in analysis, DENDRO clusters the cells based on true underlining mutation 343 profiles, and are robust to changes in total gene expression. As expected, the numbers of cells, the 344 depth of sequencing, the actual number of subclonal mutations and the phylogenetic tree structure all 345 influence the power of DENDRO. 398 ** 6 7 = log 1 ( *7 , *+7 | *7 , *+7 , * = *+ ) 399 = log P *7 , * 6 7 *7 , * 6 7 , * = * 6 + P( *7 , * 6 7 | *7 , * 6 7 , * ≠ *+ ) ( *7 , *+7 | *7 , *+7 , * = *+ ) ) 400 where * = ( *-, *< , … *7 , … */ ) are the mutation allele read counts for cell and * = 401 ( *-, *< , … *7 , … */ ) are the total read counts at these sites. More intuitively, if cells and ′ are not 402 from the same clonal group, the numerator has larger value compared to denominator. Thus **+ 7 is 403 large, indicating bigger divergence between the two cells. With further derivation (see Methods), **+ 7 is 404 a function of the five following probabilities: 405 **+ 7 406 = 7 ; *7 *7 , *7 = 0 ; *7 *7 , *7 = 1 ; * 6 7 * 6 7 , * 6 7 = 0 ; * 6 7 * 6 7 , * 6 7 = 1 407 where *7 ∈ 0,1 is SNA indicator for cell at site and 7 = ( 7 = 1) is mutation frequency across 408 the cells estimated by GATK calls.
409
In the above formula for **+ 7 , *7 *7 , *7 = 0 and * 6 7 *7 , *7 = 0 reflect reverse- Figure S5 ) "ward.D" based hierarchical clustering performs the best.
430
To determine the number of clusters we use an intra-cluster divergence curve computed from the 431 divergence matrix. Existing software rely on AIC, BIC, or another model selection metric, [39, 62] .
432
However, since we only have the "distance" matrix, these traditional methods cannot be applied. where is number of reads at a site and the first bases ( ≤ ) be the same to reference and the rests 459 are same to alternative allele. is the sequencing error and rare RNA-editing combined rate. Given 460 mutation profiles, DENDRO then constructs a phylogenetic tree with the neighbor-joining method, 461 which can more accurately capture the evolutionary relationship between different subclones [65] than 462 the initial tree given by hierarchical clustering.
464
Differential gene expression, mutation annotation and gene ontology analysis 465
We used Seurat and scDD to identify differentially expressed genes between tumors and between tumor 466 subclones [43] [44] [45] . For each comparison, we used two different methods: MAST implemented by Seurat 467 and scDD. Genes with adjusted p-value < 0.05 counts as significant differentially expressed gene for each 468 method. We further intersect these two sets of differentially expressed genes to increase robustness.
469
Subclonal mutations are annotated by ANNOVAR with default parameters and variants associated with 
